|
|
|
Volumn 54 Suppl 3, Issue , 2012, Pages
|
|
[Therapeutic update in tuberous sclerosis complex: the role of mTOR pathway inhibitors].;Actualizacion terapeutica en el complejo esclerosis tuberosa: el papel de los inhibidores de la via mTOR.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICONVULSIVE AGENT;
DRUG DERIVATIVE;
EVEROLIMUS;
MTOR PROTEIN, HUMAN;
RAPAMYCIN;
TARGET OF RAPAMYCIN KINASE;
TEMSIROLIMUS;
TUBERIN;
TUBEROUS SCLEROSIS COMPLEX 1 PROTEIN;
TUMOR SUPPRESSOR PROTEIN;
ASTROCYTOMA;
AUTISM;
BRAIN DISEASE;
BRAIN TUMOR;
DRUG ANTAGONISM;
DRUG DESIGN;
DRUG EFFECT;
EPENDYMOMA;
EPILEPSY;
GENETICS;
HAMARTOMA;
HUMAN;
INTELLECTUAL IMPAIRMENT;
LEARNING DISORDER;
MOLECULARLY TARGETED THERAPY;
PATHOLOGY;
PHYSIOLOGY;
PSYCHOLOGICAL ASPECT;
REVIEW;
SIGNAL TRANSDUCTION;
TUBEROUS SCLEROSIS;
ANTICONVULSANTS;
ASTROCYTOMA;
AUTISTIC DISORDER;
BRAIN DISEASES;
BRAIN NEOPLASMS;
DRUG DESIGN;
EPILEPSY;
GLIOMA, SUBEPENDYMAL;
HAMARTOMA;
HUMANS;
INTELLECTUAL DISABILITY;
LEARNING DISORDERS;
MOLECULAR TARGETED THERAPY;
SIGNAL TRANSDUCTION;
SIROLIMUS;
TOR SERINE-THREONINE KINASES;
TUBEROUS SCLEROSIS;
TUMOR SUPPRESSOR PROTEINS;
|
|
EID: 84872951908
PISSN: None
EISSN: 15766578
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (10)
|
|
References (0)
|
